Henry Schein (HSIC) Stock Price, News & Analysis

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings or view top-rated stocks.

11 brokers have issued 1-year target prices for Henry Schein's shares. Their HSIC share price targets range from $65.00 to $96.00. On average, they anticipate the company's share price to reach $81.09 in the next year. This suggests a possible upside of 14.4% from the stock's current price.
View analysts price targets for HSIC or view top-rated stocks among Wall Street analysts.

Henry Schein's stock was trading at $75.71 at the beginning of 2024. Since then, HSIC stock has decreased by 6.4% and is now trading at $70.86.
View the best growth stocks for 2024 here.

Henry Schein saw a decrease in short interest in March. As of March 31st, there was short interest totaling 5,500,000 shares, a decrease of 6.8% from the March 15th total of 5,900,000 shares. Based on an average daily trading volume, of 1,140,000 shares, the days-to-cover ratio is presently 4.8 days. Approximately 4.3% of the shares of the stock are short sold.
View Henry Schein's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our HSIC earnings forecast.

Henry Schein will be holding an earnings conference call on Tuesday, May 7th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Henry Schein, Inc. (NASDAQ:HSIC) issued its quarterly earnings results on Tuesday, February, 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by $0.04. The firm earned $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a trailing twelve-month return on equity of 14.03%. The business's quarterly revenue was down 10.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.21 EPS.
Read the conference call transcript.

ETFs with the largest weight of Henry Schein (NASDAQ:HSIC) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), American Century Focused Large Cap Value ETF (FLV), Invesco Bloomberg Analyst Rating Improvers ETF (RYJ), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), Democratic Large Cap Core ETF (DEMZ), First Trust Health Care AlphaDEX Fund (FXH) and VictoryShares US Small Mid Cap Value Momentum ETF (USVM).

Shares of Henry Schein split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Henry Schein declared that its Board of Directors has initiated a stock buyback plan on Thursday, August 18th 2022, which authorizes the company to buyback $400,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 4% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board of directors believes its shares are undervalued.

Henry Schein updated its FY24 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of $5.00 to $5.16 for the period, compared to the consensus estimate of $5.10. The company issued revenue guidance of +8 to +12% yr/yr or $13.326 billion to $13.820 billion, compared to the consensus revenue estimate of $12.93 billion.

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Henry Schein's stock is owned by many different retail and institutional investors. Top institutional investors include Perpetual Ltd (1.88%), Sumitomo Mitsui Trust Holdings Inc. (0.26%), Everett Harris & Co. CA (0.09%), Baker Ellis Asset Management LLC (0.04%), Galibier Capital Management Ltd. (0.04%) and Bridge Creek Capital Management LLC (0.03%). Insiders that own company stock include Bradford C Connett, David B Brous Jr, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Philip A Laskawy, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.